Article Details

Gilead and Gritstone Ink $785 Million+ Deal to Develop HIV Cure

Retrieved on: 2021-02-01 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Gilead and Gritstone Ink $785 Million+ Deal to Develop HIV Cure. View article details on hiswai:

Excerpt

Gritstone has two key technology platforms. One is its proprietary machine learning platform, Gritstone EDGE, that predicts antigens presented on the ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up